Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
US-2015087675-A1 · Mar 26, 2015 · US
Gladerma Res & Dev holds 1 patent in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 1 |
| Recent patents | 0 |
| First publication | Mar 26, 2015 |
| Latest publication | Mar 26, 2015 |
Year-over-year patent counts for this assignee.
Not enough yearly data to assess filing trend yet.
| Year | Patents |
|---|---|
| 2015 | 1 |
| Year | Patents |
|---|---|
| 2015 | 1 |
Latest publications where this party is an assignee.
Representative or frequently cited publications from precomputed assignee stats.
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 1 |
| Chemistry & Metallurgy | 1 |